Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325949 · ClinicalTrials.gov registry record · Phase 3
A Study of Pain Relief in Low Back Pain
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 770
- Enrollment target
NCT00325949 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 770 participants.
The verdict
NCT00325949, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 770 participants
- Enrollment target
Study Summary
This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain
Interventions
- DRUG placebo
- DRUG Extended release hydrocodone and acetaminophen (Vicodin CR)
- DRUG hydrocodone/acetaminophen extended release (Vicodin CR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 770 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00325949
The ClinicalTrials.gov registry entry for NCT00325949 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 770 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00325949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00325949 about?
NCT00325949 is a clinical study titled "A Study of Pain Relief in Low Back Pain". This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain
What is the current status of trial NCT00325949?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 770 participants. The study started on 2006-05. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00325949?
The interventions under investigation include: placebo (DRUG), Extended release hydrocodone and acetaminophen (Vicodin CR) (DRUG), hydrocodone/acetaminophen extended release (Vicodin CR) (DRUG).
Who is sponsoring clinical trial NCT00325949?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.